Clinical trial
Atomoxetine and Huntington's Disease
NCT00368849 · University of Iowa, Other · Completed
Key facts
| NCT number | NCT00368849 |
|---|---|
| Title | Atomoxetine and Huntington's Disease |
| Official title | Atomoxetine for Attention Deficits in Adults With Mild HD: A Randomized, Placebo-Controlled Crossover Study |
| Lead sponsor | University of Iowa, Other |
| Collaborators | Eli Lilly and Company Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Huntington Disease, Chorea |
| Intervention type | Drug |
| Interventions | atomoxetine, Matching Placebo |
| Enrollment | 20 |
| Start date | Nov 1, 2005 |
| Primary completion | Feb 1, 2008 |
| Completion | Feb 1, 2008 |
| First posted | Aug 29, 2006 |
| Last update posted | Dec 20, 2012 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: